Delasos L, Wei W, Hassan KA, Pennell NA, et al. Clinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab. Clin Lung Cancer 2023;24:e205-e213.
PMID: 37188597